Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Infectious agent detection by nucleic acid (DNA or RNA); Streptococcus, group A, direct probe technique

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 87650 refers to a laboratory test designed for the detection of the infectious agent known as Streptococcus, group A (GAS) through the use of nucleic acid techniques, specifically targeting DNA or RNA. This test is crucial in identifying the presence of GAS, which is primarily transmitted via respiratory droplets and direct contact with infected skin lesions, such as those seen in impetigo. Additionally, there have been instances of transmission through contaminated food and water. The clinical manifestations of GAS infections are diverse, commonly presenting as respiratory and skin infections, but can also lead to more severe conditions such as meningitis, osteomyelitis, toxic shock syndrome, and necrotizing fasciitis. The direct probe technique utilized in this test focuses on identifying a unique nucleic acid sequence, referred to as the target sequence, specific to the GAS bacterium. This is achieved by using a probe that is labeled with either fluorescent or chemiluminescent markers. During the testing process, the sample is treated to release nucleic acids from the target organism, if present. The labeled probe then selectively binds to the matching target sequence, forming a stable hybrid. Ribosomal RNA is often the target of this detection method due to its abundance in microorganisms, as it is typically present in thousands of copies compared to the limited 1-2 copies found in genomic DNA. For enhanced sensitivity, an amplified probe technique (CPT® Code 87651) may be employed, which involves exponentially multiplying the target sequence of GAS DNA or RNA into millions of copies. The polymerase chain reaction (PCR) or reverse transcriptase polymerase chain reaction (RT-PCR) are the most commonly used amplification methods. Furthermore, nucleic acid detection with quantification (CPT® Code 87652) allows for an assessment of the quantity of microorganisms present by utilizing quantitative or real-time PCR to amplify the isolated nucleic acid segment and generate reports documenting the absolute or relative amounts of the known nucleic acid sequence at each stage of the process.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The CPT® Code 87650 is indicated for the detection of Streptococcus, group A (GAS) in various clinical scenarios. The following conditions and symptoms may warrant the use of this test:

  • Respiratory Infections - Patients presenting with symptoms such as sore throat, fever, and difficulty swallowing may be tested for GAS to confirm the diagnosis of streptococcal pharyngitis or other respiratory infections.
  • Skin Infections - Individuals with skin lesions, particularly those resembling impetigo, may require testing to identify GAS as the causative agent.
  • Meningitis - In cases of suspected meningitis, especially in children, the test can help determine if GAS is involved in the infection.
  • Osteomyelitis - Patients with bone infections may be tested for GAS to guide appropriate treatment.
  • Toxic Shock Syndrome - The test may be indicated in patients exhibiting signs of toxic shock syndrome, a severe condition often associated with GAS.
  • Necrotizing Fasciitis - In cases of rapidly progressing soft tissue infections, testing for GAS can be critical for timely intervention.

2. Procedure

The procedure for CPT® Code 87650 involves several key steps to ensure accurate detection of Streptococcus, group A. The following outlines the procedural steps:

  • Sample Collection - A specimen is collected from the patient, which may include throat swabs, skin lesions, or other relevant samples depending on the suspected site of infection.
  • Sample Preparation - The collected sample is treated to release nucleic acids from the target organism, if present. This step is crucial for isolating the genetic material necessary for detection.
  • Probe Application - A labeled probe, which is specific to the target sequence of GAS, is introduced to the prepared sample. This probe is designed to bind only to the unique nucleic acid sequence of the GAS bacterium.
  • Hybridization - The labeled probe combines with the target sequence, forming a stable hybrid. This hybridization is essential for the subsequent detection of the GAS nucleic acid.
  • Detection - The presence of the hybrid is detected using fluorescent or chemiluminescent methods, allowing for the identification of GAS in the sample.

3. Post-Procedure

After the completion of the procedure associated with CPT® Code 87650, the laboratory will analyze the results and report the findings. The expected outcome is a clear indication of whether Streptococcus, group A is present in the sample. If GAS is detected, appropriate clinical management and treatment options can be discussed with the patient. It is important for healthcare providers to interpret the results in conjunction with clinical findings and other diagnostic tests. Follow-up care may be necessary depending on the patient's condition and the results of the test.

Short Descr STREP A DNA DIR PROBE
Medium Descr IADNA STREPTOCOCCUS GROUP A DIRECT PROBE TQ
Long Descr Infectious agent detection by nucleic acid (DNA or RNA); Streptococcus, group A, direct probe technique
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) Yes
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 206 - Microscopic examination (bacterial smear, culture, toxicology)
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
TA Left foot, great toe
T6 Right foot, second digit
T5 Right foot, great toe
T1 Left foot, second digit
T9 Right foot, fifth digit
GW Service not related to the hospice patient's terminal condition
LT Left side (used to identify procedures performed on the left side of the body)
T2 Left foot, third digit
T3 Left foot, fourth digit
T4 Left foot, fifth digit
T7 Right foot, third digit
T8 Right foot, fourth digit
XS Separate structure, a service that is distinct because it was performed on a separate organ/structure
XU Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service
Date
Action
Notes
2011-01-01 Changed Short description changed.
1998-01-01 Added First appearance in code book in 1998.
Code
Description
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"